Genmab | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
Agios Pharmaceuticals USD 1.47B 74.43M 2025-03
Almirall EUR 1.49B 1.81M 2024-12
Amarin USD 531.38M 20.5M 2024-09
Amgen USD 6.21B 330M 2025-03
argenx SE 4.26B 3.84B 2024-09
AstraZeneca USD 41.04B 168M 2025-03
Bayer EUR 32.58B 537M 2025-03
BioMarin Pharmaceutical USD 5.79B 135.47M 2025-03
Demant DKK 9.56B 42M 2024-12
Exelixis USD 2.13B 113.18M 2025-04
Fresenius Medical Care EUR 15.5B 928.44M 2025-03
Galapagos EUR 2.75B 149.05M 2025-03
Genmab DKK 5.3B 31.4B 2025-03
GlaxoSmithKline GBP 14.16B 486M 2025-03
GN Store Nord DKK 10.75B 72M 2025-03
GRIFOLS EUR 5.64B 244.27M 2025-03
Hikma Pharmaceutical USD 2.29B 88M 2024-06
Insmed USD 99.16M 186.22M 2025-03
Lonza CHF 9.33B 23M 2024-12
Merck EUR 29.99B 1.66B 2024-12
Novartis USD 44.05B 605M 2024-12
Regeneron Pharmaceuticals USD 29.39B 34M 2025-03
Roche Holding CHF 36.16B 3.28B 2024-12
Sanofi 74.07B 3.78B 2025-03
UCB EUR 10.03B 1.08B 2024-12



Genmab Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.